Heart Rate Variability in Extracorporeal Membrane Oxygenation (ECMO) Patients

Heart Rate Variability Clinical Trial

Official title:

Clinical Application of Multimodal Physiological Signal Analysis in Critical Ill Patients Depending on Extracorporeal Membrane Oxygenation

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01247727
• Other study ID #: 201010075R
• Status: Not yet recruiting
• Phase: N/A
• First received: November 22, 2010
• Last updated: April 21, 2011
• Start date: July 2011
• Est. completion date: December 2012

Study information

• Verified date: March 2011
• Source: National Taiwan University Hospital
• Contact: Jin-Ming Wu, M.D.
• Phone: 886-0972653213
• Email: kptkptkpt[@]yahoo.com.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

National Taiwan University Hospital is the leading center for care of patients with extracorporeal membrane oxygenation (ECMO). The predictable factors associated with outcomes are still lacking in patients with the ECMO support. The aim of this study is to collect the electrical signals stored in the monitor of intensive care units (ICUs), which are analyzed by the bio-informatics software. The pre-, peri-, and post-ECMO heart rate variability, including linear and non-linear analysis is calculated to address the association with outcomes of patients with ECMO. In addition, we collected the demographics, body temperature, respiratory rate, and blood pressure to investigate the causes of heart rate variability.

Description:

Inclusion criteria:Adults patients (aged older than 18 years; less than 90 years old) used ECMO for cardiopulmonary support

Exclusion criteria:

1. Patients used illicit drugs

2. Patients received heart transplantation

3. Patients have the history of arrhythmia

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 40
• Est. completion date: December 2012
• Est. primary completion date: December 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Adults patients (aged > 18 years; less than 90 years old) used ECMO for cardiopulmonary support

Exclusion Criteria:

• Patients used illicit drugs

• Patients received heart transplantation

• Patients have the history of arrhythmia

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Heart Rate Variability

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (1)

Lead Sponsor	Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan,